Signal: AbbVie ends multi-million dollar cancer drug deal with I-Mab
The biopharma giant's decision to end its partnership with I-Mab follows it ending a trial for the drug early.
Deals
Signal: CMR Surgical Raises $165m to continue development of surgical robot
Signal: Illumina leads $15m investment in Broken String Biosciences
Signal: Roche to refile subcutaneous Tecentriq with FDA after UK approval
Signal: Kroger to pay up to $1.4bn to settle opioid crisis lawsuits
Signal: Pharma giant Novartis to spin-off generics brand
Signal: UK clinical research provider Ergomed bought out in $888m deal
Signal: Gilead targets inflammation and cancer with Tentatrix R&D partnership
